Skip to content

Patient agreement to improve secondary prevention after acute myocardial infarction

Patient agreement to improve secondary prevention after acute myocardial infarction - Patient contract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038230
Enrollment
250
Registered
2026-01-14
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction I21

Interventions

Group 1: Interventional: The intervention group receives a patient agreement listing medication and target values, which is signed by the patient and the treating physician. Group 2: Control intervent

Sponsors

Stiftung Institut für Herzinfarktforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: acute myocardial infarction Written Informed Consent

Exclusion criteria

Exclusion criteria: 1. participation in another randomised trial 2. forseeable problems to perform 6-month telephon follow-up 3. problems to understand the content of the patient contract

Design outcomes

Primary

MeasureTime frame
Correct patient knowledge 6 months after discharge: - guideline-compliant target values ??for LDL cholesterol, systolic blood pressure, and the need for physical exercise (simultaneously).

Secondary

MeasureTime frame
correct patient knowledge about individual guideline target values - for LDL-cholesterin - for systolich blood pressure - diet - exercise - smoking cessation Actual target guideline adherent values - LDL-cholesterin - for systolic blood pressure - diet - exercise - smoking cessation

Countries

Germany

Contacts

Public ContactUwe Zeymer

Stiftung Institut für Herzinfarktforschung

Uwe.Zeymer@ihf.de+49 621 503 2888

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026